CMS Administrator Seema Verma announced on Wednesday (Oct. 21) that, after listening to stakeholder feedback, the agency will delay the mandatory radiation oncology demonstration until July, giving providers an extra six months before the model goes into effect. “The @CMSGov team & I have ...
CMS’s New Radiation Oncology Model: What Providers Need to Know Now that we’re a few weeks removed from the initial announcement, it’s time for cancer center leaders and providers to roll up their sleeves and figure out how to get ready for this program, which begins July 1, 2021....
doi:10.1080/10463356.2019.1656004Blair Burnett
Quantifying the Benefits of Precision Oncology Community Oncologists Say Proposed CMS Updates to E/M Services Undermine Patient Care Trial Investigators Discuss FDA Draft Guidance on Master Protocols New Radiation Therapy Guidelines for Prostate Cancer Lowers Treatment Burden and Cost Antibiotics Red...
Portenoy RK. et al., Cancer-related fatigue: guidelines for evaluation and management, The oncologist. 999, 4:1-10. Primary Examiner: SEHARASEYON, JEGATHEESAN Attorney, Agent or Firm: EAGLE IP LIMITED (Memphis, TENNESSEE, US) Claims: What is claimed is: 1. A method of decreasing blood...
On May 12, 2023, CMS introduced guidelines restricting MIPs from delivering cancer-specific medications by mail or to oncology satellite offices and also requiring patients themselves to pick up the medications in person. This regulatory change has had a devastating impact on patients with cancer in...
radiation) has been advocated in cases of unresectable and recurrent tumors, although the value of this treatment approach is unknown due to the pau- city of data.8 There is limited evidence for orthotopic cardiac transplantation in otherwise unresectable SCS, provid- ing survival of up to 3 ...
programs. Accordingly, the subject of a False Claims Act inquiry must view the implications of a False Claims Act investigation as a serious matter.Because False Claims Act investi- gations may involve civil, adminis- trative, criminal and a variety of state common law allegations (including ...
and be ready for the physician review, then such an au- tomated process will facilitate broader utilization of deformable dose accumu- lation technology."Other challenges that have been re- solved to some degree involve the ac- curacy of the deformable registration algorithms for contour propagatio...
Others have reported similar concerns, where 15% of N3c patients had SCLN posterior to the transverse vertebral process, with level V represent- ing 21% of the total SCLNs identified by PET/CT.7 Indiscriminate application of contouring guidelines without con- sideration for specific patient ...